Core Insights - Mirion Technologies, Inc. (NYSE:MIR) is recognized as one of the best stocks to buy for investment, with shares increasing over 73% in the past year as of January 27 [1] - Analysts show strong confidence in MIR, with 89% rating it a Buy and a median price target of $29, indicating an upside potential of nearly 14% [1] - Morgan Stanley has initiated coverage of MIR with an Equal Weight rating and a price target of $29, reflecting optimism about the company's growth prospects in the nuclear power sector [2][3] Company Overview - Mirion Technologies specializes in radiation detection, measurement, analysis, and monitoring products and services, operating through two segments: Medical and Nuclear & Safety [4] - The company's nuclear power solutions are utilized in over 95% of the world's nuclear reactors, while its medical products are present in 80% of cancer centers globally [3] Market Position and Strategy - The recent acquisition of Paragon Energy Solutions enhances Mirion's safety-related offerings for nuclear power plants and strengthens its position in the small modular reactor (SMR) market [3] - Analysts believe that the company will benefit from the increasing global nuclear power generation capacity, driven by the growth of data centers and the rapid adoption of new technologies [3]

Core Insights - Mirion reported strong financial performance in Q3 2025, driven by growth in the nuclear power sector, aligning with its 2025 guidance [2][4] - The company announced the acquisition of Paragon Energy Solutions to enhance its nuclear power offerings, which is expected to increase nuclear revenue to approximately 45% of total revenue [2][3] - Mirion has a significant order pipeline, including a $10 million order for small modular reactors and a $55 million order for the Asia installed base, contributing to a total of $350 million in potential orders [3] Financial Performance - Revenue growth is projected at approximately 7.0% – 9.0%, with organic revenue growth expected to be around 4.5% – 6.0% [7] - Adjusted EBITDA is forecasted to be between $223 million and $233 million, with an adjusted EBITDA margin of approximately 24.0% – 25.0% [7] - Adjusted Free Cash Flow is anticipated to be between $100 million and $115 million, an increase from the previous range of $95 million – $115 million [7] Guidance and Future Outlook - The company raised the lower end of its adjusted Free Cash Flow guidance while reaffirming other financial metrics for 2025 [4] - Mirion plans to share its 2026 expectations in February 2026, indicating confidence in its operational strategy [4] - The guidance does not account for the impact of the Paragon acquisition, suggesting potential for further growth [5]